Transdermal delivery of drugs for urologic applications: Basic principles and applications

被引：40

作者：

Nitti, VW

Sanders, S

Staskin, DR

Dmochowski, RR

Sand, PK

MacDiarmid, S

Maibach, HI

机构：

[1] NYU, Sch Med, Dept Urol, Div Voiding Dysfunct & Female Urol, New York, NY 10016 USA

[2] Watson Labs, Morristown, NJ USA

[3] New York Presbyterian Hosp, New York, NY USA

[4] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[5] Northwestern Univ, Sch Med, Evanston, IL USA

[6] Wake Forest Univ, Winston Salem, NC 27109 USA

[7] Univ Calif San Francisco, Sch Med, San Francisco, CA USA

来源：

UROLOGY | 2006年 / 67卷 / 04期

关键词：

D O I：

10.1016/j.urology.2005.11.039

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：657 / 664

页数：8

共 61 条

[1]

*ALZA CORP, 2003, DITR XL PACK INS

[2]

*ALZA CORP, 2003, DITR PACK INS

[3]

Pharmacokinetics, metabolism, and saliva output during transidermal and extended-release oral oxybutynin administration in healthy subjects [J].

Appell, RA ;

Chancellor, MB ;

Zobrist, RH ;

Thomas, H ;

Sanders, SW .

MAYO CLINIC PROCEEDINGS, 2003, 78 (06) :696-702

[4]

BASAK SC, 1997, E PHARM, V40, P63

[5]

MONITORING SERUM CONCENTRATIONS FOR ONCE-DAILY NETILMICIN DOSING REGIMENS [J].

BLASER, J ;

KONIG, C ;

SIMMEN, HP ;

THURNHEER, U .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) :341-348

[6]

BOGNER RH, 2005, TRANSDERMAL DRUG D 2

[7]

The 500 Dalton rule for the skin penetration of chemical compounds and drugs [J].

Bos, JD ;

Meinardi, MMHM .

EXPERIMENTAL DERMATOLOGY, 2000, 9 (03) :165-169

[8]

Bronaugh R, 1999, Percutaneous absorption : drugs-cosmetics-mechanisms-methodology

[9]

The role of dihydrotestosterone in benign prostatic hyperplasia [J].

Carson, C ;

Rittmaster, R .

UROLOGY, 2003, 61 (04) :2-7

[10]

Heat-associated increase in transdermal fentanyl absorption [J].

Carter, KA .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (02) :191-192

← 1 2 3 4 5 6 7 →